Karyopharm Therapeutics (KPTI) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.42
-3.01
-1.61
-0.2

Details

Expected EPS
-4.419286
Actual EPS
-2.77
Surprise EPS
1.65
Surprise Percent
+37.32%

Description

⁨Karyopharm Therapeutics⁩ (⁦KPTI⁩) has reported earnings of ⁦-2.77⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts